// you're reading...

News

Licensing expired for beta-lactoglobulin immunoassays

Since 1996, ImmunoSigns – previous CHB-Consult, has given license to R-Biopharm, Darmstadt, Germany, to commercialise a beta-lactoglobulin immunoassay (BLG-ELISA), especially design to measure degraded BLG in infant food formulas, and other food items. The License expired by December 2004. A new license contract on nisin immunoassays (Nisin ELISA) applicable in testing food conserved by this bacteriocin has been negotiated by not yet completed.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart